Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
ID: 340214Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/340214

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)" aimed at supporting studies that identify, develop, and test strategies to overcome barriers to the adoption and sustainability of evidence-based health interventions. The initiative particularly encourages research that promotes equitable dissemination among underrepresented communities and addresses the decline of health services exacerbated by the COVID-19 pandemic. Eligible applicants include a wide range of organizations such as academic institutions, nonprofits, and government entities, with funding available for small grants up to $50,000 for projects lasting two years. Interested parties should submit their applications by May 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. For more details, visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-106-Full-Announcement.html
    PAR-22-106.html
    The Department of Health and Human Services is offering a funding opportunity to support dissemination and implementation research aimed at improving the uptake, adaptation, and sustainability of evidence-based health interventions. The specific focus is on understanding and overcoming barriers to integrating effective health practices across public health and clinical settings, particularly for underrepresented communities. This Research Opportunity Announcement (PAR-22-106) encourages studies that address the decline of evidence-based health services due to the COVID-19 pandemic and seek to promote health equity. Eligible applicants include a diverse range of organizations, including academic institutions, nonprofits, and government entities. The funding allows for small grants up to $50,000 for projects lasting two years, with a focus on diverse methodologies and stakeholder engagement in research processes. Applications will be evaluated based on significance, innovation, approach, and the qualifications of the principal investigators. The initiative aims to close the gap between research findings and practical applications, ensuring that effective health interventions are widely adopted to improve community health outcomes.
    Similar Opportunities
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that addresses barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages studies that promote equitable dissemination among underrepresented communities and explore the de-implementation of ineffective practices, emphasizing the importance of interdisciplinary collaboration and stakeholder engagement. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and government organizations, with funding amounts determined by NIH appropriations and the quality of applications. The application deadline is May 7, 2025, and interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)" aimed at developing medical technologies that address health disparities among underserved populations in the U.S. This initiative encourages grant applications focused on creating effective, affordable, culturally acceptable, and accessible medical solutions, including devices, imaging systems, and telehealth innovations, while emphasizing the importance of formal collaborations with healthcare organizations serving these populations. The NIH plans to allocate approximately $2.4 million for this initiative, with an award ceiling of $500,000 per project, and expects to fund 3-4 awards over a project duration of up to four years. Interested applicants must submit their proposals by May 2, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Community Level Interventions to Improve Minority Health and Reduce Health Disparities" (R01 - Clinical Trial Optional), aimed at supporting research that develops and tests community-level interventions to enhance minority health and mitigate health disparities. Applicants are encouraged to form collaborative partnerships with community organizations and must focus on innovative, sustainable initiatives that address health disparities through community-level determinants, employing a conceptual model to connect interventions with health outcomes. The grant provides up to $1 million in direct costs per year for a project duration of up to five years, with applications due by January 7, 2027. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-231.html.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) to support small-scale research projects that can be completed in a short timeframe with limited resources. This program is designed to fund various types of research, including pilot studies, secondary data analysis, and the development of research methodologies, while explicitly excluding clinical trials. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with each application allowed to request up to $50,000 per year for a project duration not exceeding two years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R03 Small Grant Program to enhance clinical trial readiness for rare diseases, disorders, and syndromes. This initiative aims to support research that identifies critical needs for advancing therapeutics or diagnostics in rare diseases, which are defined as affecting fewer than 200,000 individuals in the U.S., by developing better biomarkers, clinical outcome measures, and insights into the natural history of these conditions. The program emphasizes the importance of partnerships among researchers, industry, and patient advocacy groups to optimize clinical trial designs, while explicitly stating that applications should not propose clinical trials directly but focus on pre-trial research activities. The maximum funding available for each project is $100,000 over a two-year period, with applications due by October 17, 2024. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-160.html.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Basic Research in Cancer Health Disparities" under the R21 Exploratory/Developmental Research Grant mechanism. This initiative aims to support innovative research investigating the biological and genetic factors contributing to cancer health disparities among various racial and ethnic populations, with a focus on mechanistic studies and the development of new methodologies. The program is designed to foster collaboration among researchers and enhance resources in the field, ultimately leading to a better understanding of cancer disparities. Applications can be submitted starting September 16, 2024, with a budget cap of $275,000 over two years, and the submission deadline is November 16, 2024. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-291.html.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials that align with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This grant program is designed to fund small research projects with a maximum budget of $50,000 in direct costs per year, for a duration of up to two years, focusing on areas such as human development, childhood development, and rehabilitation medicine. Eligible applicants include a diverse range of organizations, including higher education institutions, nonprofits, for-profits, and tribal governments, with all applications required to propose clinical trials and adhere to NIH submission guidelines. Interested parties should note that the application deadline is January 7, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further inquiries. More information can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-21-221.html.